Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
EHA: J&J chalks up early-stage myeloma win for Talvey/Darzalex combo
J&J's MonumenTAL-3 phase 3 study of bispecific antibody Talvey and Darzalex Faspro in earlier-stage multiple myeloma earned a plenary spot at EHA.
Zoey Becker
Jun 13, 2026 6:00am
J&J data set up Imaavy for expansion to treat anemic disorder
Jun 11, 2026 10:36am
AbbVie's Skyrizi nabs May's top ad spending spot over Tremfya
Jun 9, 2026 3:33pm
Fierce Biotech
At CNPV hearing, industry support meets ‘concern’ from experts
Jun 5, 2026 5:00am
Zevra CEO drafts big ambitions for Miplyffa's US adoption curve
Jun 3, 2026 11:17am
ASCO: J&J positions Erleada to shake up prostate cancer care
May 31, 2026 8:00am
